We are live on ! Find out more
MESO

Mesoblast
MESO

72 hedge funds and large institutions have $36.8M invested in Mesoblast in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

30% more call options, than puts

Call options by funds: $7.27M | Put options by funds: $5.59M

6% more funds holding

Funds holding: 68 → 72 (+4)

2.34% more ownership

Funds ownership: 0.31% → 2.65% (+2.3%)

14% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 21

25% less capital invested

Capital invested by funds: $49.2M → $36.8M (-$12.4M)

Holders
72
Holders Change
+4
Holders Change %
+5.88%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
18
Reduced
21
Closed
11
Calls
$7.27M
Puts
$5.59M
Net Calls
+$1.69M
Net Calls Change
+$1.16M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$1.77M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$848K
3
UBS Group
UBS Group
Switzerland
+$599K
4
Two Sigma Investments
Two Sigma Investments
New York
+$372K
5
Verition Fund Management
Verition Fund Management
Connecticut
+$323K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$4.62M
2
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$1.87M
3
Group One Trading
Group One Trading
Illinois
-$676K
4
CSS
Cubist Systematic Strategies
Connecticut
-$669K
5
BlackRock
BlackRock
New York
-$651K

MESO Hedge Fund Activity: Q2 2025 in Review

72 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2025, worth a combined $36.8M — down 25% from $49.2M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new MESO positions and 11 closed out — a net gain of 5 holders — while 18 added to existing stakes and 21 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $1.77M. The largest seller was Citadel Advisors, cutting an estimated $4.62M.

  • 72 institutional investors held Mesoblast (MESO) as of Q2 2025, up from 68 in Q1 2025.
  • Funds reported $36.8M of Mesoblast stock for Q2 2025, down 25% quarter-over-quarter.
  • 16 funds opened new Mesoblast positions in Q2 2025 and 11 closed out, a net change of +5 holders.
  • The largest Mesoblast buyer in Q2 2025 was Goldman Sachs, an estimated $1.77M added.
  • The largest Mesoblast seller in Q2 2025 was Citadel Advisors, an estimated $4.62M sold.

Based on aggregated 13F filings for Q2 2025.